IVRO.US Invitro International

Healthcare Biotechnology USA Stocks
0.0700 USD
Close of Nov 10, 2026
0.0452 0.1600
Market cap
USD 1.56M
P/E
-
P/B
0.92x
ROE
2.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is IVRO.US undervalued?

Graham number

The Graham number of Invitro International cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Invitro International fundamental analysis

No fundamental analysis for Invitro International yet.

Invitro International stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Invitro International

InVitro International, Inc. Develops and markets test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provid…

Full company profile